| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
intersectin 2 | 0.711 | 0.423 | 9.8E-13 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 3 | 0.570 | 0.885 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
kinesin family member 16B | 0.792 | 0.423 | 2.1E-19 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
WD repeat containing planar cell polarity effector | 0.576 | 0.769 | 1.1E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
LUC7 like 2, pre-mRNA splicing factor | 1.000 | 0.077 | 2.8E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
Rap guanine nucleotide exchange factor 6 | 0.821 | 0.308 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
phosphatidylinositol glycan anchor biosynthesis class X | 0.780 | 0.308 | 2.4E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
peroxisomal biogenesis factor 14 | 0.592 | 0.692 | 0.23 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
mannosidase beta | 0.736 | 0.462 | 1.3E-18 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
mediator complex subunit 1 | 0.573 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
basonuclin 2 | 0.612 | 0.615 | 0.93 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2015 | ||||||||
|
histone deacetylase 7 | 0.597 | 0.654 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ovo like transcriptional repressor 1 | 0.716 | 0.423 | 0.88 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
PDZ domain containing ring finger 4 | 0.805 | 0.269 | 9.1E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
formiminotransferase cyclodeaminase N-terminal like | 0.890 | 0.192 | 0.41 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
DPPA2 upstream binding RNA | 0.861 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
maestro heat like repeat family member 7 | 0.890 | 0.154 | 4.8E-24 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
negative regulator of reactive oxygen species | 0.861 | 0.231 | 0.33 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
kinesin family member 11 | 0.560 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
keratin 81 | 0.659 | 0.462 | 1.2E-18 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
chromosome 4 open reading frame 50 | 0.931 | 0.154 | 7.7E-19 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
cancer susceptibility 15 | 0.603 | 0.577 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
HLA complex group 18 | 0.722 | 0.538 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 |